Representative working for Mukesh Ambani’s TV channel makes desperate attempt to praise Narendra Modi, put in place by WHO official


A representative working for Mukesh Ambani-owned TV channel on Wednesday made a desperate attempt to praise Prime Minister Narendra for playing a key role in the approval of Covaxin by the World Health Organisation. Little did Marya Shakil know that she would face public humiliation from the WHO’s Director of Communications, who refuted her claims.

Shakil, whose Twitter bio describes her as the political editor of CNN-News18, shared a photo of Modi with WHO head Tedros Adhanom Ghebreyesus as she wrote, “A meeting that sealed this. Sources say PM Modi pushed for Covaxin approval at G20 with @DrTedros.”

Moments later, WHO’s Director of Communications refuted her claims publicly as she quoted her tweet to issue a clarification. Gabby Stern wrote, “Hi, @WHO’s process for assessing #COVID19 vaccines for emergency use listing is rigorous, scientific and standardized. It involves outside experts on a technical advisory group who review data from manufacturers and others to ensure efficacy and safety. Thanks!”

This prompted Twitterati to target Shakil for her attempts to indulge in sychophancy.

Bujt Shakil wasn’t the only TV representative from a pro-government TV channel to praise Modi for the approval of Covaxin by the WHO.

Here’s how other TV representatives from other pro-government TV channels reacted, using identical lines.


Curiously, this was exactly the line used by BJP functionaries, giving rise to speculations that representatives from pro-government TV channels simply indulged in ‘copy and paste’ job in their attempt to glorify the Indian PM.

Here’s how BJP functionaries reacted.



The WHO on Wednesday granted its approval to Covaxin for the emergency use listing. The WHO said, “The Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that the #Covaxin vaccine meets WHO standards for protection against #COVID19, that the benefit of the vaccine far outweighs risks & the vaccine can be used.”

It added, “#Covaxin vaccine was also reviewed by WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), and recommended use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above. #COVID19.”